Anbio Biotechnology Class A Ordinary Shares
NNNNStockNASDAQ
$15.59 ▼ 5.17%
12 juin 2026
N
Anbio Biotechnology Class A Ordinary Shares
$15.59 ▼ 5.17%
12 juin 2026
NNNNStockNASDAQ

01 / À propos

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets. Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Arberion
Loading market data